HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2

Benzinga Newsdesk www.benzinga.com Negative 77.8%

Neg 77.8% Neu 0% Pos 0%

HC Wainwright & Co. analyst Yi Chen maintains Envoy Medical (NASDAQ:COCH) with a Buy and lowers the price target from $2.5 to $2.